Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
2269:HKG
WuXi Biologics (Cayman) Inc
HK$33.48
-1.30%
(-0.44) 1D
Apr 24, 2:24:32 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2269...
Open
HK$33.60
High
HK$33.86
Low
HK$33.02
Mkt. cap
138.62B
Avg. vol.
27.80M
Volume
13.44M
P/E ratio
25.13
52-wk high
HK$44.00
52-wk low
HK$21.60
EPS
HK$1.33
Shares outstanding
1.23B
No. of employees
13K
News stories
From sources across the web
Profile
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development. WuXi Biologics' roots date back to 2010, and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017. As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore. In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong. In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
About WuXi Biologics (Cayman) Inc
CEOZhisheng Chen
Employees13.3K
Founded2010
Headquarters-
SectorHealth care
Websitewuxibiologics.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
4.98B
4.98B
5.92B
5.92B
Cost of goods sold
2.85B
2.85B
3.04B
3.04B
Cost of revenue
2.85B
2.85B
3.04B
3.04B
Research and development expenses
171.76M
171.76M
254.93M
254.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
525.62M
525.62M
631.03M
631.03M
Operating expense
764.30M
764.30M
921.71M
921.71M
Total operating expenses
3.61B
3.61B
3.96B
3.96B
Operating income
1.36B
1.36B
1.96B
1.96B
Other non operating income
54.16M
54.16M
-283.76M
-283.76M
EBT including unusual items
1.66B
1.66B
1.96B
1.96B
EBT excluding unusual items
1.48B
1.48B
1.62B
1.62B
Income tax expense
285.74M
285.74M
476.10M
476.10M
Effective tax rate
17.17%
17.17%
24.24%
24.24%
Other operating expenses
-
-
-
-
Net income
1.17B
1.17B
1.28B
1.28B
Net profit margin
23.50%
23.50%
21.70%
21.70%
Earnings per share
-
-
-
-
Interest and investment income
102.03M
102.03M
115.29M
115.29M
Interest expense
-41.77M
-41.77M
-29.76M
-29.76M
Net interest expenses
60.26M
60.26M
85.53M
85.53M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.72B
1.72B
2.32B
2.28B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer